Page last updated: 2024-11-03

1,2,5,8-tetrahydroxy anthraquinone and Melanoma

1,2,5,8-tetrahydroxy anthraquinone has been researched along with Melanoma in 1 studies

1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Luo, YH1
Li, JQ1
Zhang, Y2
Wang, JR1
Xu, WT1
Feng, YC1
Li, SZ1
Jin, CH1

Other Studies

1 other study available for 1,2,5,8-tetrahydroxy anthraquinone and Melanoma

ArticleYear
Quinalizarin induces cycle arrest and apoptosis via reactive oxygen species-mediated signaling pathways in human melanoma A375 cells.
    Drug development research, 2019, Volume: 80, Issue:8

    Topics: Anthraquinones; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Prolif

2019